This is
the first part of our interview with cardiology pioneer Richard K.
Myler, M.D., who with Andreas Gruentzig
performed the first coronary angioplasty in the operating room in
San Francisco in May 1977. On March 1, 1978, Dr. Myler performed the
first coronary angioplasty in a cath lab in the United States. Dr.
Myler was a close associate and friend of Gruentzig, and in this exclusive
multi-part interview he traces the history of this procedure, and
offers some perspective on the current state of interventional cardiology.
 
In the early 80's, Dr. Myler
founded the San Francisco Heart Institute at Seton Medical Center,
and has spent the past twenty years teaching the practice of interventional
cardiology to physicians all over the world. He is the recipient of
numerous awards and has published many papers throughout his long
and distinguished career. Dr. Myler was recently
honored with the dedication of a new state-of-the-art catheterization
lab at Seton Medical Center.
Q: When did you first hear of "angioplasty"? Myler: The word angioplasty was developed by Dr.
Charles Dotter in response to a technique that he and one of his
(at that time) young associates, Melvin Judkins, developed in Portland,
Oregon for opening up blocked arteries in the legs. Dr. Dotter derived
it from the Greek words -- "angio", vessel -- and "plasty", capable
of being molded -- and called their technique "transluminal angioplasty".
In 1968 or '69 at the American Heart Association
meeting in Atlantic City, Dr. Dotter presented his work. He showed
a short movie in which tracks in the snow suggested there might
be some compression of plaque.
In the movie there was a volcanic eruption.
It was very dramatic. Just at the end of the movie he made a comment,
a reference to the fact that though it was used in the legs, some
day it might be used in other systems, including the coronary arteries.
Sitting in the audience, with perhaps 60 or
80 people, I was stunned, absolutely stunned. The idea seemed so
original and so simple.
We had just landed on the moon, and I thought,
if we can scoop up "moon dust" 387,000 miles from earth, could we
not reach across a one meter catheter and somehow affect a plaque
that was just a few milligrams in weight, and yet threatened a human
life?
With that thought bubbling in my mind, I
called a friend who was also at the meeting -- John
Abele, then the president of a small company in Watertown, Massachusetts
called Medi-Tech. John was also taken with this possibility. They
had worked in their company on some other devices, not necessarily
for the coronaries, but John is an extraordinarily imaginative man
and asked an associate of his, Itzhak Bentov, to work on a prototype.
We had this in hand within one year.
early angioplasty
device,
circa 1970
This was a 3.5F small catheter with
a little cage device on the end which by opening would push material
aside and as it closed it captured the material within it and then
could be withdrawn. This was never used in a clinical trial.
But John continued to show interest, and I continued
to show interest and he would call me or we would visit together at
one coast or another or at a meeting and we would chat about this.
It was in 1976, he called me from the apartment of this young man
in Zurich who had performed an angioplasty technique in dogs' coronaries.
He said that this man, whose name was Andreas Gruentzig, was on to
something and it would be good if we met. We chatted for a moment
on the phone and set up an opportunity to meet him at the American
Heart meeting in November.
I recall going up to meet Dr. Gruentzig
who had a poster of this animal work. Most people who walked by him
raised their eyes to the ceiling, implying, "this is kind of nuts!"
-- which, by the way, was precisely the look I saw in the audience
when Charles Dotter presented it some years earlier.
Andreas Gruentzig's
poster
exhibit at American Heart
Association (1976)
John introduced me and my wife Sharon to Andreas. We'd spoken on
the phone and we'd written back and forth so we were prepared to meet
each other. I looked at the poster and I remember turning to my wife
and saying, "For God's sake, it's a balloon! It's a balloon...". And
then after we talked for a while, I turned to Sharon and said, "We
have to go to Zurich...now!"
Myler,
Zeitler, Dotter & Gruentzig in Nuremburg, 1977
The next time we met face to face was in March of 1977 and the place
was Nuremberg and the department was Dr. Eberhart Zeitler's 1st
International Angioplasty Symposium. Of course, it reflected the
peripheral work because no one had done coronary work.
I think there were three Americans there at
the time: Dr. Dotter, a very nice fellow named Dave Kumpe, a radiologist
from Denver, and myself. There were no more than 40 people in this
small classroom and on the blackboard behind Dr. Zeitler was a list
of all the places that did peripheral angioplasty in 1977 -- there
were about 10 or 12.
Andreas was very much influenced by Dotter
through his exposure to Dr. Zeitler. I've often said that Dr. Zeitler
was really the "St. Paul" of angioplasty because he was able to introduce
it in a very positive way in Europe. That was a frustration of Dr.
Dotter in the United States since most physicians who did vascular
work were surgeons and at that time and thereafter were very dubious
of this procedure in the peripheral vessels.
 
send comments & suggestions
to "info at angioplasty dot org"
Read our Privacy statement.
Angioplasty.Org is an editorially independent informational health
site
which has received unrestricted educational grants from Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY